Search results
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga· 5 days agoThe study showed AstraZeneca's sipavibart (formerly AZD3152), an investigational long-acting...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via AOL· 5 days agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...
Top pharma executives say lack of funding stalling digital revolution
BioPharma-Reporter· 5 hours agoThe study, titled Disconnected Pharma, is based on 100 in-depth interviews with executives from...
News Highlights: Top Company News of the Day - Tuesday at 7 AM ET
Morningstar· 6 hours agoLowe's Cos. Inc.'s stock rose 2.2% premarket Tuesday, after the home-improvement retailer posted better-than-expected first-quarter earnings as a decline in big ticket spending was partially ...
Medical company plans $225M investment, 274 jobs at West Chester
The Hamilton Journal News· 3 hours agoNational Resilience Inc., which operates as Resilience, purchased the former AstraZeneca facility on...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 5 days agoWhile AstraZeneca’s globally used COVID-19 vaccine is leaving the scene, the British Big Pharma is...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AOL· 4 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug ...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots |...
The State· 5 days agoSince last week, hundreds of social media posts and news stories have claimed that AstraZeneca is removing its COVID vaccine from the market after admitting it caused blood ...
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 4 days agoAstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly...
AstraZeneca selects new heart failure target with BenevolentAI
Pharmaceutical Technology via Yahoo Finance· 5 days agoAstraZeneca has incorporated a new target for heart failure treatment into its discovery portfolio...